Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.08.29
第三届董事会第十五次聚会决议通告
2015.08.29
关于新增召募资金专项存储账户的通告
2015.08.29
关于设立新药基金的通告
2015.08.29
董事会关于召募资金2015年半年度存放与使用的专项报告
2015.08.28
2015年第一次暂时股东大会的执法意见书
2015.08.28
2015年第一次暂时股东大会决议通告
2015.08.28
关于回购部分社会公众股份债权人通知的通告
2015.08.25
关于全资子公司以现金收购Cytovance Biologics,Inc.股权的通告
2015.08.25
关于申请内保外贷暨为全资子公司提供反担保的通告
2015.08.25
拟收购Cytovance Biologics,Inc.股权涉及的Cytovance Biologics,Inc.股东所有权益评估...
第一页
上一页
94
95
96
97
98
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】